Facial reconstruction

Search LJMU Research Online

Browse Repository | Browse E-Theses

What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcomes trials?

Banach, M and Penson, PE (2019) What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcomes trials? Cardiovascular Research, 115 (3). pp. 26-31. ISSN 0008-6363

[img]
Preview
Text
Cardiovascular Research Onlife.pdf - Accepted Version

Download (746kB) | Preview
Item Type: Article
Additional Information: This is a pre-copyedited, author-produced version of an article accepted for publication in Cardiovascular Research following peer review. The version of record Maciej Banach, Peter E Penson; What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER?, Cardiovascular Research, Volume 115, Issue 3, 1 March 2019, Pages e26–e31, is available online at: http://dx.doi.org/10.1093/cvr/cvy301
Uncontrolled Keywords: 1102 Cardiorespiratory Medicine and Haematology
Subjects: R Medicine > RM Therapeutics. Pharmacology
Divisions: Pharmacy & Biomolecular Sciences
Publisher: Oxford University Press (OUP)
Related URLs:
Date Deposited: 26 Feb 2019 09:08
Last Modified: 03 Jan 2020 08:00
DOI or Identification number: 10.1093/cvr/cvy301
URI: https://researchonline.ljmu.ac.uk/id/eprint/10210

Actions (login required)

View Item View Item